These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 13813266)

  • 21. [Studies on influenza immunity. I. Results with PR 8 and FM 1 strains].
    HERZBERG K; MAY G; BECK H
    Z Immun exp ther; 1955 Dec; 112(5-6):409-19. PubMed ID: 13312443
    [No Abstract]   [Full Text] [Related]  

  • 22. [Method for verifying the activity of the vaccine against influenza].
    LACORTE JG; MONTEIRO E; LOURES JC
    Hospital (Rio J); 1960 May; 57():955-8. PubMed ID: 14413330
    [No Abstract]   [Full Text] [Related]  

  • 23. [Experimental study of influenza-diphtheria-whooping cough vaccine. (Part II) Immunological reaction to diphtheria and whooping cough antigen].
    APANASHCHENKO NI; SOKOLOVA NN; ZHDANOV VM
    Vopr Virusol; 1960; 5():57-61. PubMed ID: 13793931
    [No Abstract]   [Full Text] [Related]  

  • 24. [Study, by means of the conditioned reflex method, of the immunogenic power of formolized rabies and influenza vaccines].
    NICOLAU SS; MIRZA L; SAMUEL I
    Stud Cercet Inframicrobiol; 1961; 12(Suppl)():175-93. PubMed ID: 14479542
    [No Abstract]   [Full Text] [Related]  

  • 25. [Comparative investigation on effectiveness of living influenza egg vaccine and of its variation vaccine TChE].
    SOKOLOV MI; KULIKOVA KS
    Vopr Virusol; 1956; 1(1):31-5. PubMed ID: 13352960
    [No Abstract]   [Full Text] [Related]  

  • 26. TESTING influenza vaccines.
    Public Health Rep (1896); 1957 Oct; 72(10):861-4. PubMed ID: 13465950
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of cupriporphyrin on antigenicity and pyrogenicity of influenza virus vaccine.
    FREEMAN MD; STANTON HT; BARNARD RD; GOLDMAN B
    Ann Allergy; 1956; 14(1):82-7. PubMed ID: 13292830
    [No Abstract]   [Full Text] [Related]  

  • 28. Active immunization with influenza virus A and B in infants and children.
    GLAZIER MM; BENENSON AS; WHEELER RE
    Pediatrics; 1956 Apr; 17(4):482-8. PubMed ID: 13310081
    [No Abstract]   [Full Text] [Related]  

  • 29. Problems of allocation and distribution of influenza vaccines.
    DAVIS DJ
    Am Rev Respir Dis; 1961 Feb; 83(2)Pt 2():168-70. PubMed ID: 13720155
    [No Abstract]   [Full Text] [Related]  

  • 30. Studies on influenza virus. IV. Studies on the influenza virus vaccine immunization experiment of man with influenza virus vaccine inactivated with sodium ethylmercurithiosalicylate.
    NAGAKI D; HAGA T; IWASAKI K; NAKASE Y; UCHIYAMA T
    Kitasato Arch Exp Med; 1954 Jun; 27(1-2):1-7. PubMed ID: 13296317
    [No Abstract]   [Full Text] [Related]  

  • 31. Aerosol and nasal delivery of vaccines and antiviral drugs against seasonal and pandemic influenza.
    Wong JP; Christopher ME; Viswanathan S; Schnell G; Dai X; Van Loon D; Stephen ER
    Expert Rev Respir Med; 2010 Apr; 4(2):171-7. PubMed ID: 20406083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T lymphocytes as an indicator in influenza vaccination, influenza and acute respiratory diseases.
    Rudenko LG; Zoshchenkova NY; Tunkun TI; Shamanova MG; Zykov MP; Starshov PD
    Acta Virol; 1978 Mar; 22(2):167-9. PubMed ID: 26203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is there a role for a mucosal influenza vaccine in the elderly?
    Corrigan EM; Clancy RL
    Drugs Aging; 1999 Sep; 15(3):169-81. PubMed ID: 10503810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunogenic properties of living anti-influenza vaccine and causes of infection of vaccinated subjects].
    ZAKSTEL'SKAIA LIa; IAKHNO MA; EFINOVA VA
    Vopr Virusol; 1957; 2(4):213-9. PubMed ID: 13530878
    [No Abstract]   [Full Text] [Related]  

  • 35. Inactivated influenza virus vaccines. Past, present, and future.
    DAVENPORT FM
    Am Rev Respir Dis; 1961 Feb; 83(2)Pt 2():146-56. PubMed ID: 13719955
    [No Abstract]   [Full Text] [Related]  

  • 36. [Evaluation of the postvaccination level of influenza antibodies by means of the radial immunodiffusion and hemagglutination inhibition reactions].
    Vavilova IuG; Gorev NE; Zykov MP
    Vopr Virusol; 1976; (2):158-61. PubMed ID: 820079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on influenza virus. III. Studies on the influenza virus vaccine; immunization experiment of mice with the influenza virus vaccine inactivated by sodium ethylmercurithiosalicylate.
    NAGAKI D; IWASAKI K; HOMMA S; NAKASE Y; UCHIYAMA T
    Kitasato Arch Exp Med; 1953 Dec; 26(4):209-15. PubMed ID: 13286892
    [No Abstract]   [Full Text] [Related]  

  • 38. [On the epidemiological effectiveness of live anti-influenza vaccines of types A2 and A, A1, B].
    BERLIANT ML
    Vopr Virusol; 1960; 5():50-2. PubMed ID: 13799540
    [No Abstract]   [Full Text] [Related]  

  • 39. Vaccination against influenza.
    FRANCIS T
    Bull World Health Organ; 1953; 8(5-6):725-41. PubMed ID: 13094502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A micromethod for complement fixation reaction used for the serodiagnosis of influenza and acute catarrhs of the upper respiratory tract].
    SELIVANOV AA
    Vopr Virusol; 1959; 4():663-9. PubMed ID: 14444717
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.